CrossRef 17. Ojeda R, de Paz JL, Barrientos AG, Martín-Lomas M, Penadés S: Preparation of multifunctional glyconanoparticles as a platform for potential carbohydrate-based anticancer vaccines. Carbohydr Res 2007, 342:448–459.CrossRef 18. Kim H-D, Maxwell JA, Kong selleck chemicals F-K, Tang DC, Fukuchi K: Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Nutlin-3a supplier Abeta1–6: toward safer and effective vaccines against Alzheimer’s disease. Biochem Biophys Res Commun 2005, 336:84–92.CrossRef 19. Yankai Z, Rong Y, Yi H, Wentao L, Rongyue C, Ming Y, Taiming L, Jingjing L, Jie W: Ten tandem repeats of beta-hCG 109–118 enhance immunogenicity and anti-tumor effects of beta-hCG C-terminal peptide
carried by mycobacterial heat-shock protein HSP65. Biochem Biophys Res Commun 2006, 345:1365–1371.CrossRef 20. Bergen JM, von Recum HA, Goodman TT, Massey AP, Pun SH: Gold nanoparticles as a versatile platform for optimizing physicochemical parameters for targeted
drug delivery. Macromol Biosci 2006, 6:506–516.CrossRef 21. Grabarek Z, Gergely J: Zero-length crosslinking procedure with the use of active esters. Anal Biochem 1990, 185:131–135.CrossRef 22. Overwijk WW, Tsung A, Irvine KR, Parkhurst MR, Goletz TJ, Tsung K, Carroll MW, Liu C, Moss B, Rosenberg SA, Restifo NP: gp100/pmel 17 is a murine tumor rejection antigen: induction of “self”-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. Crenolanib clinical trial J Exp Med 1998, 188:277–286.CrossRef 23. Mansour M, Pohajdak B, Kast WM, Fuentes-Ortega A, Korets-Smith E, Weir GM, Brown RG, Daftarian P: Therapy of established B16-F10 melanoma tumors by a single vaccination of CTL/T helper peptides in VacciMax. J Transl Med 2007, 5:20.CrossRef 24. Schmittel
A, Keilholz U, Scheibenbogen Paclitaxel price C: Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral blood. J Immunol Methods 1997, 210:167–174.CrossRef 25. Overwijk WW, Theoret MR, Finkelstein SE, Surman DR, de Jong LA, Vyth-Dreese FA, Dellemijn TA, Antony PA, Spiess PJ, Palmer DC, Heimann DM, Klebanoff CA, Yu Z, Hwang LN, Feigenbaum L, Kruisbeek AM, Rosenberg SA, Restifo NP: Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 2003, 198:569–580.CrossRef 26. Abbas AK, Lichtman AH: Basic Immunology: Functions and Disorders of the Immune System. Philadelphia: Elsevier Saunders; 2006. 27. Moon JJ, Suh H, Bershteyn A, Stephan MT, Liu H, Huang B, Sohail M, Luo S, Ho Um S, Khant H, Goodwin JT, Ramos J, Chiu W, Irvine DJ: Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater 2011, 10:243–251.CrossRef 28. Good NE, Winget GD, Winter W, Connolly TN, Izawa S, Singh RMM: Hydrogen ion buffers for biological research. Biochemistry 1966, 5:467–477.CrossRef 29. Hermanson GT: Bioconjugate Techniques. Waltham: Academic Press; 2008.